Prime Capital Investment Advisors, LLC Biomarin Pharmaceutical Inc Transaction History
Prime Capital Investment Advisors, LLC
- $6.63 Billion
- Q2 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 2,868 shares of BMRN stock, worth $202,423. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,868
Previous 5,013
42.79%
Holding current value
$202,423
Previous $437,000
46.0%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding BMRN
# of Institutions
632Shares Held
185MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.6 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.34 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.33 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$983 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$684 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $13.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...